2022 - Research.com Best Female Scientist Award
Keiko Ozato mostly deals with Molecular biology, Transcription factor, Cell biology, Interferon regulatory factors and Transcription. Her Molecular biology research incorporates elements of Bromodomain, Antigen, Chromatin, RNA polymerase II and Monoclonal antibody. Keiko Ozato combines subjects such as Interferon, Chromatin immunoprecipitation and Cellular differentiation with her study of Transcription factor.
Keiko Ozato has researched Cell biology in several fields, including Cell growth, Coactivator, RNA, Immunology and Histone. Her work carried out in the field of Immunology brings together such families of science as Haematopoiesis and Gene expression. Keiko Ozato interconnects Interleukin 12, Signal transduction, Regulatory sequence and RANK Ligand in the investigation of issues within Interferon regulatory factors.
Her primary areas of investigation include Molecular biology, Cell biology, Transcription factor, IRF8 and Immunology. Her Molecular biology research is multidisciplinary, incorporating elements of Transcription, Gene expression, Gene, Antigen and Antibody. Keiko Ozato has included themes like Retinoid X receptor and RNA polymerase II in her Transcription study.
Her Cell biology research incorporates themes from Cellular differentiation, Interferon, Dendritic cell, Histone and Regulation of gene expression. Bromodomain is closely connected to Chromatin in her research, which is encompassed under the umbrella topic of Transcription factor. Her research integrates issues of Haematopoiesis, Myeloid, Cancer research, Progenitor cell and Monocyte in her study of IRF8.
Keiko Ozato focuses on Cell biology, IRF8, Transcription factor, Immunology and Molecular biology. Her Cell biology research is multidisciplinary, incorporating perspectives in Chromatin, Histone, Epigenetics and Myeloid. The concepts of her IRF8 study are interwoven with issues in Haematopoiesis, Cellular differentiation, Monocyte, Progenitor cell and Interferon regulatory factors.
Her Interferon regulatory factors study which covers Microglia that intersects with Gene expression and Cancer research. Her studies in Transcription factor integrate themes in fields like Regulation of gene expression, Dendritic cell, Bone marrow and Transcriptome. Her Molecular biology study combines topics from a wide range of disciplines, such as Transcription factor II B, Chromatin immunoprecipitation, General transcription factor, Promoter and Glucocorticoid receptor.
Keiko Ozato spends much of her time researching IRF8, Cell biology, Transcription factor, Molecular biology and Cellular differentiation. Her study in IRF8 is interdisciplinary in nature, drawing from both Myeloid, Cancer research, Immunology, Microglia and Interferon regulatory factors. Her Cell biology research includes elements of CD28, Cytotoxic T cell, ZAP70 and Antigen-presenting cell.
Her Transcription factor study incorporates themes from SENP1, Regulation of gene expression and Transcription. The study incorporates disciplines such as Transcription coregulator, Chromatin remodeling, Histone acetyltransferase, Nucleosome and Histone methylation in addition to Molecular biology. The Cellular differentiation study combines topics in areas such as Enhancer, T cell, Haematopoiesis and Monocyte.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.
Moon Kyoo Jang;Kazuki Mochizuki;Meisheng Zhou;Ho-Sang Jeong.
Molecular Cell (2005)
Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.
K Ozato;N Mayer;D H Sachs.
Journal of Immunology (1980)
A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo.
Mitchell H. Rosner;Mitchell H. Rosner;M. Alessandra Vigano;Keiko Ozato;Paula M. Timmons.
Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers.
Hansjorg Keller;Christine Dreyer;Jeffrey Medin;Abderrahim Mahfoudi.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Recruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4
Zhiyuan Yang;Jasper H.N. Yik;Ruichuan Chen;Ruichuan Chen;Nanhai He.
Molecular Cell (2005)
TRIM family proteins and their emerging roles in innate immunity
Keiko Ozato;Dong-Mi Shin;Tsung-Hsien Chang;Herbert C. Morse.
Nature Reviews Immunology (2008)
Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.
K Ozato;D H Sachs.
Journal of Immunology (1981)
Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene
Thomas Holtschke;Jürgen Löhler;Yuka Kanno;Thomas Fehr.
The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis
Anup Dey;Farideh Chitsaz;Asim Abbasi;Tom Misteli.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Monoclonal antibodies to mouse major histocompatibility complex antigens.
Keiko Ozato;Nanci M. Mayer;David H. Sachs.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: